Monika Lewinska, Ph.D.
@lewinskamonika
Researching metabolic stress, liver diseases and cancer metabolism at BRIC, University of Copenhagen, Denmark.
ID: 1192366900409511936
07-11-2019 09:03:31
561 Tweet
270 Takipçi
628 Takip Edilen
What a blast! ILCA with laura kulik Marco Sanduzzi Zamparelli Monika Lewinska, Ph.D. ken liu, phd plus Marina Bárcena Varela Amanda Craig and #NuriaCodina
After 7 years at AndersenLab it was time to say goodbye as I am starting a new scientific journey at Gubra. Many thanks to all my colleagues who made the last 7 years memorable. Juan LB Yuewan Luo Bichitra Paul Yangngam S (Mai) Marvelmario Gabriel ASAP_BRIC Biotech Research & Innovation Centre (BRIC)
🚀Takeoff of Precision-BTC-Network Happy to coordinate with chiara braconi an interdisciplinary network to promote personalized approaches for patients with biliary cancer 👩🏽🔬🧑🔬>40 countries EASLnews ILCA my_UEG AMMF Cholangiocarcinoma Foundation Apply to join: cost.eu/actions/CA2212…
New paper out describing the role of #Fibroblast-derived lysyl oxidase increases oxidative phosphorylation and stemness in #cholangiocarcinoma Gastroenterology by Monika Lewinska, Ph.D. AndersenLab. To collaborators 🙏. EASLnews gastrojournal.org/article/S0016-…
Hot discussion on liver transplantation in #iCCA patients Cholangiocarcinoma Foundation EURO-CHOLANGIO-NET Global Cholangiocarcinoma Alliance
Typical #LiverCancerSummit dinner wherever we are we are together Maria Reig Sherrie Bhoori Marco Sanduzzi Zamparelli Gonzalo Sapisochin Ana Lleo Arndt Vogel Jean-Charles Nault Anna Saborowski Valerie Chew Julien Calderaro Ciro Celsa EASL Education
Huge congratulations to Dr. Bichitra Paul for a successful defence! 👏 linkedin.com/posts/bichitra…
FDA approved trastuzumab deruxtecan for previously treated unresectable or metastatic HER2-positive solid cancers 👉first tumor-agnostic approval for antibody-drug conjugate targeting HER2-positive tumors 👉More options for many GI-cancers, incl. CRC & BTC ESMO - Eur. Oncology Cholangiocarcinoma Foundation